71 search results for lung cancer
Scientific Publications
: 10.1038/s41416-020-0737-6. Epub 2020 Feb 10.https://pubmed.ncbi.nlm.nih.gov/32037403/ Lung Cancer Myall NJ, patients with advanced non-small cell lung cancer. J Thorac Dis 2024. doi: 10.21037/jtd-23https, With and Without Atezolizumab in Stage IV Nonsquamous Non–Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked. Clinical Lung Cancer Published:May 10, 2023 DOI:https://doi.org/10.1016/j.cllc.2023.05.003. https://www.clinical-lung-cancer.com/article/S1525-7304
https://www.nccn.org/education-research/nccn-oncology-research-program/scientific-publicationscancer_across_life_span
cancer_across_life_span, East 4 Bag It 4 CANCER101 5 Cancer Support Community 8 CLL Society 10 Debbie’s D ream, decisions. URL: cancer101.org Phone number: 646-638-2202 Email: [email protected] CANCER101 Planner, n f o c u s e d o n i m p roving outcomes for people with lung cancer through research, education, is a peer-to-peer support program that matches lung cancer patients or caregivers with other lung cancer survivors or caregivers who have walked the lung cancer journey. T h e s e s u p p o r t m e n t
https://www.nccn.org/docs/default-source/oncology-policy-program/cancer_across_life_span.pdf?sfvrsn=1b738f08_2Imaging AUC Compendium Reviewer Acknowledgement
Memorial Sloan Kettering Cancer Center Central Nervous System Cancers, Cancer Institute at the University of Utah Lung Cancer Screening, Yale Cancer Center/Smilow Cancer Hospital Small Cell Lung Cancer, Rogel Cancer Center Basal Cell Skin Cancer Jeremy Bordeaux, MD, MPH Case Comprehensive Cancer Center/University Hospitals Seidman Cancer
https://www.nccn.org/compendia-templates/compendia/imaging-appropriate-use-criteria-nccn-imaging-auc/imaging-auc-compendium-reviewer-acknowledgementDrugs and Biologics Reviewer Acknowledgement
Kettering Cancer Center Central Nervous System Cancers Louis B, UT Southwestern Simmons Comprehensive Cancer Center Head and Neck Cancers, Gotlib, MS, MD Stanford Cancer Institute Non-Small Cell Lung Cancer, Cancer Center Pediatric Central Nervous System Cancers Nicholas, Helen Diller Family Comprehensive Cancer Center Small Cell Lung Cancer
https://www.nccn.org/compendia-templates/compendia/drugs-and-biologics-compendia/drugs-and-biologics-reviewer-acknowledgementGuidelines for Patients Translations
® Non-Small Cell Lung Cancer - Early and Locally Advanced Version 2024 (Arabic) Guidelines for Patients® Non-Small Cell Lung Cancer - Metastatic Version 2024 (Arabic, Cancer: Early Stage Version 2024 (Arabic) Guidelines for Patients® Small Cell Lung Cancer, -Small Cell Lung Cancer - Early and Locally Advanced Version 2024 (Chinese) Guidelines for Patients® Non-Small Cell Lung Cancer - Metastatic Version 2024 (Chinese) Guidelines
https://www.nccn.org/global/what-we-do/guidelines-for-patients-translationsBiomarkers Compendium Reviewer Acknowledgment
Memorial Sloan Kettering Cancer Center Biliary Tract Cancers, Vanderbilt-Ingram Cancer Center Esophageal and Esophagogastric Junction Cancers, Cancer Center Non-Small Cell Lung Cancer Dara L. Aisner, PhD, , MD Memorial Sloan Kettering Cancer Center Small Cell Lung Cancer, Diller Family Comprehensive Cancer Center Acute Myeloid Leukemia
https://www.nccn.org/compendia-templates/compendia/biomarkers-compendium/biomarkers-compendium-reviewer-acknowledgmentHIT
B-Cell Lymphomas Biliary Tract Cancers Bladder Cancer Bone Cancer Breast Cancer Castleman Disease Central Nervous System Cancers Cervical Cancer Chronic Lymphocytic Leukemia/Small Lymphocytic, and Esophagogastric Junction Cancers Gastric Cancer Gastrointestinal Stromal Tumors Gestational, Non-Small Cell Lung Cancer Occult Primary Ovarian Cancer/Fallopian Tube Cancer/Primary, Small Cell Lung Cancer Soft Tissue Sarcoma Squamous Cell Skin Cancer Systemic Light Chain
https://www.nccn.org/redirects/hitClinical Trials
Cancers Namrata Vijayvergia, MD Fox Chase Cancer Center A Multi-Center Phase I trial of Neratinib and fam-trastuzumab deruxtecan in advanced refractory gastrointestinal cancer patients Lung Cancer Yasir, EGFR Mutant Lung Cancer Nicholas Bodor, MD, PhD, MPH Fox Chase Cancer Center TH-138: Phase II, Select a cancer below for additional information on ORP active trials at NCCN Member Institutions. Gastrointestinal Scott Plotkin, MD Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts
https://www.nccn.org/education-research/nccn-oncology-research-program/clinical-trialsGuidelines Panels
Lung Cancer Screening Panel, Panel Non-Small Cell Lung Cancer, Small Cell Lung Cancer Panel, Adult Cancer Pain Panel, Bladder/Penile Cancers Panel
https://www.nccn.org/guidelines/guidelines-panels-and-disclosure/disclosure-panelsPermission to Cite or Use NCCN Content
Tract Cancers Bladder Cancer Bone Cancer Breast Cancer Breast Cancer Risk Reduction Breast, Disease Cancer-Related Fatigue Castleman Disease Central Nervous System Cancers Cervical Cancer, and Esophagogastric Junction Cancers Gastric Cancer Gastrointestinal Stromal Tumors Genetic/Familial High, Cancers Hepatocellular Carcinoma Histiocytic Neoplasms Hodgkin Lymphoma Kaposi Sarcoma Kidney Cancer Lung Cancer Screening Management of Immunotherapy-Related Toxicities Melanoma: Cutaneous
https://www.nccn.org/guidelines/permission-to-cite-or-use-nccn-contentFramework for Resource Stratification Of NCCN Guidelines
Version 3.2023 NCCN Guidelines Version 3.2025 Non-Small Cell Lung Cancer, approach for building cancer management systems to provide the highest achievable cancer care, changes to the allocation of resources, providing a structure for improving cancer care. Treatment, of the relevant NCCN Guidelines Panel with experience/knowledge in the care of patients with cancer, ) with expertise in cancer care in resource-constrained settings as identified by NCCN Framework
https://www.nccn.org/global/what-we-do/nccn-framework-for-resource-stratification-of-nccn-guidelinesGuidelines for Patients
Version: 2022 Non-Small Cell Lung Cancer - Early and Locally, Lung Cancer - Metastatic Version: 2024, Version: 2025 Lung Cancer Screening, cancer resources, lung cancer resources, immunotherapy information, lung cancer information, prostate, cancer, lung cancer, and many more
https://www.nccn.org/patientresources/patient-resources/guidelines-for-patientsResume Screening
Biliary Tract Cancers Bladder Cancer Bone Cancer Breast Cancer Castleman Disease Central Nervous System Cancers Cervical Cancer Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Chronic, Junction Cancers Gastric Cancer Gastrointestinal Stromal Tumors Gestational Trophoblastic Neoplasia, Pediatric Central Nervous System Cancers Pediatric Hodgkin Lymphoma Penile Cancer Primary Cutaneous Lymphomas Prostate Cancer Rectal Cancer Small Bowel Adenocarcinoma Small Cell Lung
https://www.nccn.org/covid-19/resume-screeningHarmonized Guidelines
3.2024 Biliary Tract Cancers Version 3.2023 Bladder Cancer Version 1.2023, Cancers Version 2.2022 Cervical Cancer Version 1.2023 Chronic Lymphocytic, Colon Cancer Version 2.2022 Esophageal and Esophagogastric Junction Cancers Version, and Adrenal Tumors Version 1.2022 Non-Small Cell Lung Cancer Version 4.2024 Occult, Rectal Cancer Version 3.2022 Small Cell Lung Cancer Version 2.2024 Soft
https://www.nccn.org/global/what-we-do/harmonized-guidelinesSpecific Populations
Cancer Resources All Lung Cancer Resources All Non-Hodgkin Lymphomas (NHL) Resources, Lung Cancer - Early and Locally Advanced Version: 2024 Non-Small Cell Lung Cancer - Metastatic Version: 2024, Small Cell Lung Cancer Version: 2024, Lung Cancer Screening Version: 2023
https://www.nccn.org/patientresources/patient-resources/guidelines-for-patients/specific-populationsTreatment by Cancer Type
Treatment by Cancer Type, Cancer Resources All Lung Cancer Resources All Non-Hodgkin Lymphomas (NHL) Resources, Lung Cancer - Early and Locally Advanced Version: 2024 Non-Small Cell Lung Cancer - Metastatic Version: 2024, Small Cell Lung Cancer Version: 2024, Lung Cancer Screening Version: 2023
https://www.nccn.org/patientresources/patient-resources/guidelines-for-patients/treatment-by-cancer-typeDetection, Prevention, and Risk Reduction
Cancer Resources All Lung Cancer Resources All Non-Hodgkin Lymphomas (NHL) Resources, Lung Cancer - Early and Locally Advanced Version: 2024 Non-Small Cell Lung Cancer - Metastatic Version: 2024, Small Cell Lung Cancer Version: 2024, Lung Cancer Screening Version: 2023
https://www.nccn.org/patientresources/patient-resources/guidelines-for-patients/detection-prevention-and-risk-reductionSupportive Care
Cancer Resources All Lung Cancer Resources All Non-Hodgkin Lymphomas (NHL) Resources, Lung Cancer - Early and Locally Advanced Version: 2024 Non-Small Cell Lung Cancer - Metastatic Version: 2024, Small Cell Lung Cancer Version: 2024, Lung Cancer Screening Version: 2023
https://www.nccn.org/patientresources/patient-resources/guidelines-for-patients/supportive-careORP Grant History
lung cancer AstraZeneca Pharmaceuticals, LP – quality improvement/ projects in ovarian cancer AstraZeneca Pharmaceuticals, LP – quality improvement/ projects in small cell lung cancer AstraZeneca Pharmaceuticals, LP – quality improvement/ projects in early-stage non-small cell lung cancer, with afatinib in lung cancer Bristol-Myers Squibb Company and ImClone Systems Incorporated, , and bevaciumab, with or without atezolizumab, in lung cancer GlaxoSmithKline LLC – pre-clinical
https://www.nccn.org/education-research/nccn-oncology-research-program/orp-grant-historyAnnual Report
/cancercenters. NCCN Member Institutions Mayo Clinic Comprehensive Cancer Center UC Davis Case, for Breast Cancer 1,318,623 Downloads NCCN Guidelines for Non-Small Cell Lung Cancer 932,195, Cell Lung Cancer are currently available in English and Vietnamese. NCCN 2024 Annual Report 18, at meetings including: - World Conference on Lung Cancer - American Association for Cancer Research, The University of Texas MD Anderson Cancer Center Improving The Detection of Other Cancers in Patients
https://www.nccn.org/docs/default-source/about/annual-report.pdf?sfvrsn=8411082_40